Difficult Discussions - Prognosis, Therapeutic Choices, End of Life

Prognosis, therapeutic choices, end of life care are three key themes for patients with lung cancer. Understanding how to design and discuss phase I clinical trials, communication tools, integration of palliative care, and financial toxicity are key themes that need to be addressed among patients and caregivers with advanced NSCLC. Initial research has demonstrated the need for all of these areas, but the medical community still has a long way to go in terms of breaking down barriers to care, improving eligibility criteria for clinical trials and communication, and the dissemination of early palliative care not only in the U.S. but globally.

Target Audience

This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and pulmonologists.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Recognize the most common symptoms of lung cancer and management.
  • Understand the different models of co-management.
  • Identify barriers and potential solutions to incorporating palliative care into different patient populations.
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
12/03/2023
Course expires: 
12/02/2025
Cost:
$0.00
Part of: 
2023 Multidisciplinary Thoracic Cancers Symposium onDemand
Rating: 
0

Moderator:

  • Madison Grogan, MPH

Speakers:

  • Jennifer Carlisle, MD
  • Kate Schueller, MD
  • Madison Grogan, MPH
  • Meera Ragavan, MD

 

Faculty:
A list of all meeting faculty and Individual presenter disclosures are linked to their names in the Schedule of Events.

Planning Committee:
A list of all meeting planning committee members and their individual disclosures can be found on the Planning Committee website page.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.